GlobeNewswire Inc.·15h ago·Ispecimen Inc.iSpecimen Raises $2.5M via Private Placement to Bolster Operations$ISPC raises $2.5M through private placement at $5.12/share. Proceeds target working capital and marketing expansion. ISPCprivate placementcommon stock
Benzinga·3d ago·Not SpecifiedPowerus Taps Decorated Military Leader for Advisory Board Ahead of Nasdaq ListingPowerus appoints retired Rear Admiral Jamie Sands III to advisory board, bolstering leadership ahead of 2026 Nasdaq merger with Aureus Greenway Holdings. AGHdefense technologymerger agreement
Benzinga·3d ago·Currenc Group Inc.Currenc Group Extends Reverse Merger Timeline with Animoca Brands to Mid-2026Currenc Group extends exclusivity period for Animoca Brands reverse merger to June 30, 2026, targeting Q3 2026 close with Animoca holding 95% stake. CRCGCURRfintechWeb3
Benzinga·3d ago·NaScilex Subsidiaries Sell ACEA Pharma to Phoenix Asia in $1B Deal, Nasdaq Listing PlannedScilex's ACEA subsidiaries sell ACEA Pharma to Phoenix Asia Holdings for $1 billion in stock, with Nasdaq listing expected by Q2 2026. SCLXSCLXWPHOEmergerpharmaceutical
GlobeNewswire Inc.·3d ago·NaScilex Subsidiaries Sell ACEA Pharma to Phoenix Asia in $1B Share DealScilex subsidiaries sell ACEA Pharma to Phoenix Asia for $1B in stock; retain 82% ownership post-Nasdaq listing in Q2 2026. SCLXSCLXWPHOEpharmaceutical companyNasdaq listing
GlobeNewswire Inc.·May 1·NaSBC Medical to Report Q1 2026 Results, Signaling Expansion ProgressSBC Medical ($SBC) will release first-quarter 2026 earnings May 14, detailing performance across its diversified clinic portfolio amid U.S. and Asian expansion. SBCSBCWWhealthcareearnings announcement
Benzinga·May 1·Badar ShaikhS&P 500 Rule Overhaul Could Fast-Track SpaceX Entry Post-IPOS&P Global proposes expedited S&P 500 entry for megacap IPOs, including SpaceX, reducing waiting period to 6 months and waiving profitability requirements. NVDAMETATSLAElon MuskNasdaq listing
GlobeNewswire Inc.·Apr 30·NaHall Chadwick Acquisition Corp II Seeks $265M Nasdaq IPO to Fund Strategic SPAC DealsBlank check company Hall Chadwick Acquisition Corp II filed for $265M Nasdaq IPO, targeting business combinations in connectivity, sustainability, and infrastructure sectors. COHNHCACHCACRHCACUIPOinfrastructure
GlobeNewswire Inc.·Apr 28·NaOIO Group Completes De Tomaso Merger, Restructures Share Class With 348M Shares OutstandingOIO Group completed De Tomaso Automobili merger on April 24, 2026, executing 1-for-3 reverse split, resulting in 348M shares outstanding. Company repositions as luxury mobility platform. OIOOIOWWbusiness combinationreverse stock split
Benzinga·Apr 27·PrnewswireZ Squared Begins Trading Post-Merger, Distributes Coeptis Holdings SharesZ Squared Inc. ($ZSQR) began trading on Nasdaq on April 27, 2026, following its Coeptis Therapeutics merger and announcing a pro rata shareholder distribution. COEPCOEPWdata centersbusiness combination
GlobeNewswire Inc.·Apr 27·NaEUDA Health Holdings Faces Nasdaq Delisting Risk Over Market Cap CollapseEUDA Health Holdings received Nasdaq notice of failed market value compliance, with 180 days to restore $35 million market cap or face delisting. EUDAEUDAWSingaporeNasdaq listing
Benzinga·Apr 24·PrnewswireZ Squared Completes Coeptis Merger, Debuts on Nasdaq as ZSQRZ Squared completes Coeptis business combination and debuts on Nasdaq as $ZSQR, creating a vertically integrated computing infrastructure operator across three states. COEPCOEPWbusiness combinationpower management
Benzinga·Apr 23·Bamboo WorksKailera's 63% IPO Surge Validates Chinese Pharma 'NewCo' Spinoff StrategyKailera Therapeutics surged 63% on Nasdaq debut as weight-loss drug spinoff from Hengrui Pharma, raising $625M and validating the 'NewCo' model for Chinese pharmaceutical companies. LLYNVOGILDJHPCYKLRAIPOGLP-1 drugs
GlobeNewswire Inc.·Apr 21·NaAMC Robotics Posts $6M Revenue in Debut Year After Nasdaq Listing, Eyes 2026 CommercializationAMC Robotics ($AMCI) reported $6.0M revenue and 48% gross margin in 2025 following Nasdaq debut, with two robotics products advancing toward commercialization. HIVEAMCISPAC mergerrobotics
Benzinga·Apr 20·Blue Moon Metals IncBlue Moon Metals to Ring Nasdaq Bell as Critical Metals Producer Eyes Public ProfileBlue Moon Metals to ring Nasdaq closing bell April 20, 2026, advancing five critical minerals projects across Norway and U.S. BMMNasdaq listingtungsten
Benzinga·Apr 18·Mohd HaiderCerebras Returns to IPO Market After Securing $850M Credit Line and Major AI DealsAI chipmaker Cerebras revived IPO plans after securing $850M credit facility and landing major partnerships with OpenAI and Amazon, targeting Nasdaq debut under $CBRS ticker. NVDAAMZNIPOAI infrastructure
GlobeNewswire Inc.·Apr 18·Redcloud Holdings PlcRedCloud Holdings Faces Nasdaq Delisting Risk After Failing Minimum Price Requirement$RCT received Nasdaq notice for failing $1 minimum bid price; has 180 days to regain compliance or face potential delisting. RCTstock priceNasdaq listing
Benzinga·Apr 14·NaGalera and Obsidian Merge in All-Stock Deal, $350M Financing Fuels TIL Therapy PushGalera and Obsidian merge in all-stock deal with $350M financing, creating Obsidian Therapeutics ($OBX) focused on TIL cell therapies with funding through 2028. GRTXclinical trialsmerger agreement
Benzinga·Apr 13·Not SpecifiedEuropean Steel Leader Trasteel to Go Public via $1.3B SPAC MergerTrasteel Holding merges with Sizzle Acquisition Corp. II in SPAC deal valuing combined company at $1.3 billion. Expected Nasdaq listing under ticker TSTL by end of 2026. SZZLSZZLRSZZLUSPAC mergerIPO
Benzinga·Apr 10·Suja Life, Inc.Cold-Pressed Juice Maker Suja Life Files for Nasdaq IPO with Goldman Sachs LeadingSuja Life files for Nasdaq IPO under ticker $SUJA with Goldman Sachs, Jefferies, and William Blair leading. Offering size and price range pending. GSGSpAGSpCGSpDJEFIPONasdaq listing